Keratoconus, Inflammatory and Epigenetic Biomarkers: An integrative review of the molecular basis and translational perspectives
DOI:
https://doi.org/10.33448/rsd-v15i2.50660Keywords:
Keratoconus, Biomarkers, Inflammation, Epigenetics, Tear film.Abstract
Introduction: Keratoconus (KC) is a multifactorial corneal ectasia in which oxidative stress, chronic low-grade inflammation, and epigenetic alterations contribute to stromal thinning and loss of corneal biomechanical integrity. Inflammatory and epigenetic biomarkers detected in tear film, corneal tissue, and peripheral blood have emerged as promising tools for early diagnosis, risk stratification, and therapeutic monitoring. Objective: To synthesize current evidence on inflammatory and epigenetic biomarkers associated with keratoconus, with emphasis on molecular markers relevant to clinical application and translational research. Methods: An integrative review was conducted using PubMed/MEDLINE, Scopus, Web of Science, and SciELO databases, covering the period from 2000 to 2025. Search terms included “keratoconus”, “biomarkers”, “inflammatory mediators”, “cytokines”, “tear film”, “epigenetics”, “DNA methylation”, and “microRNA”. Original studies and reviews addressing inflammatory or epigenetic molecular biomarkers in keratoconus were included. Results and Discussion: Increased levels of pro-inflammatory cytokines (IL-1β, IL-6, IL-8, TNF-α), matrix metalloproteinases—particularly MMP-9—and oxidative stress mediators were consistently observed in tear film and corneal tissue of keratoconus patients, correlating with disease severity and progression. Systemic markers, such as neutrophil-to-lymphocyte and monocyte-to-HDL ratios, circulating cytokines, and vitamin D levels, suggest a systemic inflammatory and metabolic component. At the epigenetic level, differentially expressed microRNAs and DNA methylation changes in genes related to extracellular matrix remodeling, stress response, and TGF-β signaling have been identified. Conclusion: Keratoconus is an inflammatory-degenerative disease modulated by genetic and epigenetic factors. Inflammatory and epigenetic biomarkers are promising tools for diagnosis and monitoring; however, methodological heterogeneity and limited longitudinal data still restrict their clinical implementation.
References
Arnal, E. (2011). Oxidative stress in keratoconus? Investigative Ophthalmology & Visual Science. 8592–8597.
Balasubramanian, S. A., Mohan, S., Pye, D. C., & Willcox, M. D. P. (2012). Proteases, proteolysis and inflammatory molecules in the tears of people with keratoconus. Acta Ophthalmologica, 90(4), e303-9. https://doi.org/10.1111/j.1755-3768.2011.02369.x.
Bawazeer, A. M., Hodge, W. G., & Lorimer, B. (2000). Atopy and keratoconus: a multivariate analysis. The British Journal of Ophthalmology, 84(8), 834–836. https://doi.org/10.1136/bjo.84.8.834.
Deshmukh, R., Ong, Z. Z., Rampat, R., Alió Del Barrio, J. L., Barua, A., Ang, M., Mehta, J. S., Said, D. G., Dua, H. S., Ambrósio, R., Jr, & Ting, D. S. J. (2023). Management of keratoconus: an updated review. Frontiers in Medicine, 10, 1212314. https://doi.org/10.3389/fmed.2023.1212314.
Dorota, M., Joanna, & Gajecka, M. (2024). Differentially expressed microRNAs targeting genes in key pathways in keratoconus. Frontiers in Genetics, 15.
Durán-Cristiano, S. C., Bustamante-Arias, A., Fernandez, G. J., Martin-Gil, A., & Carracedo, G. (2025). Omics in keratoconus: From molecular to clinical practice. Journal of Clinical Medicine, 14(7), 2459. https://doi.org/10.3390/jcm14072459.
Esteller, M. (2008). Epigenetics in cancer. The New England Journal of Medicine, 358(11), 1148–1159. https://doi.org/10.1056/NEJMra072067.
Galvis, V., Sherwin, T., Tello, A., Merayo, J., Barrera, R., & Acera, A. (2015). Keratoconus: an inflammatory disorder? Eye (London, England), 29(7), 843–859. https://doi.org/10.1038/eye.2015.63.
Goklap, O., Yildirim, Y., & Tekin, K. (2022). Epidemiology of keratoconus: a review. Saudi J Ophthalmol, 1, 10–18.
Hashemi, H. (2020). Global prevalence and incidence of keratoconus: a systematic review and meta-analysis. Am J Ophthalmol, 215, 88–97.
Hawkes, E., & Nanavaty, M. A. (2014). Eye rubbing and keratoconus: A literature review. International Journal of Keratoconus and Ectatic Corneal Diseases, 3(3), 118–121. https://doi.org/10.5005/jp-journals-10025-1090.
Kabza, M., Karolak, J. A., Rydzanicz, M., Szcześniak, M. W., Nowak, D. M., Ginter-Matuszewska, B., Polakowski, P., Ploski, R., Szaflik, J. P., & Gajecka, M. (2017). Collagen synthesis disruption and downregulation of core elements of TGF-β, Hippo, and Wnt pathways in keratoconus corneas. European Journal of Human Genetics, 25(5), 582–590. https://doi.org/10.1038/ejhg.2017.4.
Karaca, E. E., Özmen, M. C., Ekici, F., Yüksel, E., & Türkoğlu, Z. (2014). Neutrophil-to-lymphocyte ratio may predict progression in patients with keratoconus. Cornea, 33(11), 1168–1173. https://doi.org/10.1097/ico.000000000000026
Katipoğlu, Z. (2020). May monocyte/HDL cholesterol ratio (MHR) and neutrophil/lymphocyte ratio (NLR) be an indicator of inflammation and oxidative stress in patients with keratoconus? Ocular Immunology and Inflammation. 632–636.
Kenney, C., & Brown, M. (2003). The Cascade Hypothesis of Keratoconus. Contact Lens and Anterior Eye, v. 26. 139–146.
Krebs, I., Moussa, G., & Blomquist, P. H. (2021). Quality of life and economic burden of keratoconus. J Cataract Refract Surg, 4, 543–549.
Lanza, M., Benincasa, G., Costa, D., & Napoli, C. (2019). Clinical role of epigenetics and network analysis in eye diseases: A translational science review. Journal of Ophthalmology, 2019, 2424956. https://doi.org/10.1155/2019/2424956.
Lema, I., Sobrino, T., Durán, J. A., Brea, D., & Díez-Feijoo, E. (2009). Subclinical keratoconus and inflammatory molecules from tears. The British Journal of Ophthalmology, 93(6), 820–824. https://doi.org/10.1136/bjo.2008.144253.
Lin, Y., Yao, Y., Miao, X., Tang, S., & Huang, L. (2025). Integration of tear fluid biomarkers and machine learning for the early detection of keratoconus. BMC Ophthalmology, 25(1), 612. https://doi.org/10.1186/s12886-025-04451-8.
Lombardo, G., Alunni-Fegatelli, D., Serrao, S., Mencucci, R., Roszkowska, A. M., Bernava, G. M., Vestri, A., Aleo, D., & Lombardo, M. (2024). Accuracy of an air-puff dynamic tonometry biomarker to discriminate the corneal biomechanical response in patients with keratoconus. Cornea, 43(3), 315–322. https://doi.org/10.1097/ICO.0000000000003377.
Lombardo, M., Fruschelli, M., & Serrao, S. (sem data). The immunopathology of keratoconus: tear film biomarkers and immune pathways. Current Opinion in Allergy and Clinical Immunology.
Maja, Gimenez, J., Bombuy, & Izdebska, J. (2025). Etiopathogenesis of keratoconus: A contemporary overview. Seminars in Ophthalmology, 1–13.
McMonnies, C. W. (2009). Mechanisms of rubbing-related corneal trauma in keratoconus. Cornea, 28(6), 607–615. https://doi.org/10.1097/ICO.0b013e318198384f.
Nishtala, K. (2016). Tear biomarkers for keratoconus. Eye and Vision.
Passaro, M. L., Rinaldi, M., Morgera, V., Feola, A., Romano, V., Troisi, M., Strianese, D., Piscopo, R., Messina, S., Romano, A., Porcellini, A., Pezone, A., & Costagliola, C. (2025). The oxidative-stress-senescence axis in keratoconus: new insights into corneal degeneration. Frontiers in Molecular Biosciences, 12, 1539542. https://doi.org/10.3389/fmolb.2025.1539542.
Pereira, A. S. et al. (2018). Metodologia da pesquisa científica. Editora da UFSM.
Pinheiro-Costa, J., Lima Fontes, M., Luís, C., Martins, S., Soares, R., Madeira, D., Falcão-Reis, F., & Carneiro, Â. (2023). Serum inflammatory biomarkers are associated with increased choroidal thickness in keratoconus. Scientific Reports, 13(1), 10862. https://doi.org/10.1038/s41598-023-37472-8.
Risemberg, R. I. C. et al. (2026). A importância da metodologia científica no desenvolvimento de artigos científicos. E-Acadêmica. 7(1), e0171675. https://eacademica.org/eacademica/article/view/675.
Santhiago, M. R., Stival, L. R., Araujo, D. C., Antunes-Foschini, R., Toledo, M. C., Nunes, I. L. S., Morgado, C. R., & Kara-Junior, N. (2025). Relationship of inflammatory mediators (interleukin and cortisol concentrations) with corneal epithelial quantifiable metrics. Ophthalmology Science, 5(1), 100624. https://doi.org/10.1016/j.xops.2024.100624
Sharif, R., Bak-Nielsen, S., Hjortdal, J., & Karamichos, D. (2018). Pathogenesis of Keratoconus: The intriguing therapeutic potential of Prolactin-inducible protein. Progress in Retinal and Eye Research, 67, 150–167. https://doi.org/10.1016/j.preteyeres.2018.05.002.
Sood, S., Tiwari, A., Sangwan, J., Vohra, M., Sinha, N. R., Tripathi, R., Sangwan, V. S., & Mohan, R. R. (2025). Role of epigenetics in corneal health and disease. Progress in Retinal and Eye Research, 104(101318), 101318. https://doi.org/10.1016/j.preteyeres.2024.101318.
Stunf Pukl, S. (2022). Are miRNAs dynamic biomarkers in keratoconus? A review of the literature. Genes, 13(4), 588. https://doi.org/10.3390/genes13040588.
Whittemore, R., & Knafl, K. (2005). The integrative review: updated methodology. Journal of Advanced Nursing, 52(5), 546–553. https://doi.org/10.1111/j.1365-2648.2005.03621.x.
Wisse, R. (2014). Van der Lelij A. A Multivariate Analysis and Statistical Model for Predicting Visual Acuity and Keratometry One Year After Cross-linking for Keratoconus. American Journal of Ophthalmology, 519–525.
Wisse, R. P. L., Kuiper, J. J. W., Gans, R., Imhof, S., Radstake, T. R. D. J., & Van der Lelij, A. (2015). Cytokine expression in keratoconus and its corneal microenvironment: A systematic review. The Ocular Surface, 13(4), 272–283. https://doi.org/10.1016/j.jtos.2015.04.006.
Xia, Y., Chen, K., Yang, Q., Chen, Z., Jin, L., Zhang, L., Yu, X., Wang, L., Xie, C., Zhao, Y., Shen, Y., & Tong, J. (2024). Methylation in cornea and corneal diseases: a systematic review. Cell Death Discovery, 10(1), 169. https://doi.org/10.1038/s41420-024-01935-2.
Zhang, Y. (2022). MicroRNA profiling in the aqueous humor of keratoconus eyes. Translational Vision Science & Technology, 11(12).
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Camila Vercesi Gonçalves, Daniela Santos Liu, Leticia Garotti da Cunha Bueno, Luiz Felipe Ramos Bueno, Gilson Fernandes Ruivo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
